These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 383285

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of BCG-vaccine upon experimental visceral leishmaniasis in hamsters.
    Jarecki-Black JC, Glassman AB, Holbrook TW.
    Ann Clin Lab Sci; 1984; 14(6):464-6. PubMed ID: 6508226
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer.
    Sonoda T, Sugimura K, Ikemoto S, Kawashima H, Nakatani T.
    Oncol Rep; 2007 Jun; 17(6):1469-74. PubMed ID: 17487406
    [Abstract] [Full Text] [Related]

  • 25. Comparative and combined effect of BCG and neuraminidase in experimental immunotherapy.
    Simmons RL, Rios A.
    Natl Cancer Inst Monogr; 1973 Dec; 39():57-68. PubMed ID: 4595327
    [No Abstract] [Full Text] [Related]

  • 26. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
    Zbar B, Canti G, Rapp HJ, Ashley MP, Sukumar S, Bast RC.
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract] [Full Text] [Related]

  • 27. Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma.
    Bast RC, Zbar B, Mackaness GB, Rapp HJ.
    J Natl Cancer Inst; 1975 Mar; 54(3):749-56. PubMed ID: 804566
    [Abstract] [Full Text] [Related]

  • 28. The safety and immunogenicity of Bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles).
    Lesellier S, Palmer S, Dalley DJ, Davé D, Johnson L, Hewinson RG, Chambers MA.
    Vet Immunol Immunopathol; 2006 Jul 15; 112(1-2):24-37. PubMed ID: 16687176
    [Abstract] [Full Text] [Related]

  • 29. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A, Davies A, Marsh PD, Chambers MA, Hewinson RG.
    Clin Infect Dis; 2000 Jun 15; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [Abstract] [Full Text] [Related]

  • 30. Treatment of the mouse Lewis tumor by the association of radiotherapy and immunotherapy with Bacillus Calmette-Guérin.
    Dubois JB, Serrou B.
    Cancer Res; 1976 May 15; 36(5):1731-4. PubMed ID: 773530
    [Abstract] [Full Text] [Related]

  • 31. Intrapulmonary BCG cell wall vaccination in mice.
    Reuman PD, Ayoub EM.
    Microbios; 1987 May 15; 49(198):7-15. PubMed ID: 3550393
    [Abstract] [Full Text] [Related]

  • 32. Relationship of Bacillus Calmette-Guérin-induced suppressor cells to hematopoietic precursor cells.
    Bennett JA, Marsh JC.
    Cancer Res; 1980 Jan 15; 40(1):80-5. PubMed ID: 6444212
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM.
    Int J Mol Med; 2005 Oct 15; 16(4):565-71. PubMed ID: 16142388
    [Abstract] [Full Text] [Related]

  • 34. Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.
    Kadhim SA, Chin JL, Batislam E, Karlik SJ, Garcia B, Skamene E.
    J Urol; 1997 Aug 15; 158(2):646-52. PubMed ID: 9224385
    [Abstract] [Full Text] [Related]

  • 35. Neonatal vaccination with Bacillus Calmette-Guérin elicits long-term protection in mouse-allergic responses.
    Shen H, Huang H, Wang J, Ye S, Li W, Wang K, Zhang G, Wang P.
    Allergy; 2008 May 15; 63(5):555-63. PubMed ID: 18307575
    [Abstract] [Full Text] [Related]

  • 36. Identification of two subpopulations of Bacillus Calmette-Guérin (BCG) Tokyo172 substrain with different RD16 regions.
    Honda I, Seki M, Ikeda N, Yamamoto S, Yano I, Koyama A, Toida I.
    Vaccine; 2006 Jun 05; 24(23):4969-74. PubMed ID: 16621197
    [Abstract] [Full Text] [Related]

  • 37. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, Jocham D, Flad HD, Böhle A.
    Clin Cancer Res; 2000 Sep 05; 6(9):3729-38. PubMed ID: 10999767
    [Abstract] [Full Text] [Related]

  • 38. Immunoprotection against murine bladder carcinoma by octaarginine-modified liposomes incorporating cell wall of Mycobacterium bovis bacillus Calmette-Guérin.
    Joraku A, Homhuan A, Kawai K, Yamamoto T, Miyazaki J, Kogure K, Yano I, Harashima H, Akaza H.
    BJU Int; 2009 Mar 05; 103(5):686-93. PubMed ID: 19040525
    [Abstract] [Full Text] [Related]

  • 39. Clearance of viable Calmette-Guèrin bacillus by the in vitro isolated and perfused rat liver.
    Ruggiero G, Andreana A, Ninni A, Curci G, Utili R, Giusti G.
    Acta Hepatogastroenterol (Stuttg); 1977 Apr 05; 24(2):102-5. PubMed ID: 324220
    [Abstract] [Full Text] [Related]

  • 40. Effect of prior splenectomy on the growth of sarcoma 180 in normal and Bacillus Calmette-Guerin infected mice.
    OLD LJ, CLARKE DA, BENACERRAF B, STOCKERT E.
    Experientia; 1962 Jul 15; 18():335-6. PubMed ID: 14481702
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.